# TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

> **NCT03795506** · NA · UNKNOWN · sponsor: **Imperial College London** · enrollment: 96 (estimated)

## Conditions studied

- Atopic Dermatitis Eczema

## Interventions

- **DEVICE:** Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment
- **DEVICE:** Placebo TLA Device

## Key facts

- **NCT ID:** NCT03795506
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03795506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03795506, "TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03795506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*